Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 131,161 | 0 | 0 | 0 | 0 |
| Cost of Goods | 5,279 | N/A | N/A | N/A | N/A |
| Gross Profit | 125,882 | N/A | N/A | N/A | N/A |
| Operating Expenses | 343,431 | 206,064 | 146,909 | 72,743 | 13,782 |
| Operating Income | -217,270 | -206,064 | -146,909 | -72,743 | -13,782 |
| Interest Expense | 0 | 0 | 0 | 0 | 30 |
| Other Income | 128,918 | 17,147 | 4,728 | -11 | -30,031 |
| Pre-tax Income | -88,352 | -188,917 | -142,181 | -72,754 | -43,843 |
| Income Tax | 7,144 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -95,496 | -188,917 | -142,181 | -72,754 | -43,843 |
| Minority Interests | N/A | N/A | N/A | -2,109 | -3,336 |
| Net Income | $-95,496 | $-188,917 | $-142,181 | $-70,645 | $-40,507 |
| EPS Basic Total Ops | -1.02 | -2.37 | -2.17 | -4.62 | -7.33 |
| EPS Basic Continuous Ops | -1.02 | -2.37 | -2.17 | -1.97 | -7.93 |
| EPS Diluted Total Ops | -1.02 | -2.37 | -2.17 | -4.62 | -7.33 |
| EPS Diluted Continuous Ops | -1.02 | -2.37 | -2.17 | -1.97 | -7.93 |
| EPS Diluted Before Non-Recurring Items | -1.02 | -2.37 | -2.17 | -4.62 | N/A |
| EBITDA(a) | $-215,241 | $-205,681 | $-146,378 | $-72,544 | $-13,627 |